Deutsche Bank’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-19,706
| Closed | -$57K | – | 3998 |
|
|
2022
Q2 | $57K | Buy |
19,706
+724
| +4% | +$2.09K | ﹤0.01% | 3682 |
|
|
2022
Q1 | $53K | Buy |
18,982
+461
| +2% | +$1.29K | ﹤0.01% | 3750 |
|
|
2021
Q4 | $86K | Sell |
18,521
-22,190
| -55% | -$103K | ﹤0.01% | 3696 |
|
|
2021
Q3 | $346K | Buy |
40,711
+21,101
| +108% | +$179K | ﹤0.01% | 3247 |
|
|
2021
Q2 | $322K | Sell |
19,610
-84,394
| -81% | -$1.39M | ﹤0.01% | 3477 |
|
|
2021
Q1 | $2.3M | Buy |
104,004
+295
| +0.3% | +$6.52K | ﹤0.01% | 2063 |
|
|
2020
Q4 | $3.21M | Sell |
103,709
-75,012
| -42% | -$2.32M | ﹤0.01% | 1604 |
|
|
2020
Q3 | $3.63M | Buy |
178,721
+170,823
| +2,163% | +$3.47M | ﹤0.01% | 1402 |
|
|
2020
Q2 | $121K | Buy |
7,898
+4,230
| +115% | +$64.8K | ﹤0.01% | 3311 |
|
|
2020
Q1 | $28K | Sell |
3,668
-234
| -6% | -$1.79K | ﹤0.01% | 3716 |
|
|
2019
Q4 | $55K | Buy |
3,902
+801
| +26% | +$11.3K | ﹤0.01% | 3825 |
|
|
2019
Q3 | $46K | Buy |
3,101
+1,761
| +131% | +$26.1K | ﹤0.01% | 3861 |
|
|
2019
Q2 | $18K | Buy |
+1,340
| New | +$18K | ﹤0.01% | 4510 |
|